[1]LOW A, GEORGE S, HOWARD L, et al. Lung function, inflammation, and endothelin-1 in congenital heart disease-associated pulmonary arterial hypertension[J]. J Am Heart Assoc, 2018, 7(4): e007249. DOI:10.1161/JAHA.117.007249.
[2]KUEBLER W M, BONNET S, TABUCHI A. Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series)[J]. Pulm Circ, 2018, 8(2): 2045893218757596. DOI:10.1177/ 2045893218757596.
[3]BONNET S, ROCHEFORT G, SUTENDRA G, et al. The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted[J].Proc Natl Acad Sci U S A, 2007, 104(27): 11418-11423. DOI:10.1073/pnas.0610467104.
[4]CHEN R, YAN J C, LIU P J, et al. The role of nuclear factor of activated T cells in pulmonary arterial hypertension[J]. Cell Cycle, 2017, 16(6): 508-514. DOI:10.1080/15384101.2017.1281485.
[5]TANG H Y, WU K, WANG J, et al. Pathogenic role of mTORC1 and mTORC2 in pulmonary hypertension[J]. JACC Basic Transl Sci, 2018, 3(6): 744-762. DOI: 10.1016/j.jacbts.2018.08.009.
[6]YANG Z X, HAN Z B, JI Y R, et al. CD106 identifies a subpopulation ofmesenchymal stem cells with unique immunomodulatory properties[J]. PLoS ONE, 2013, 8(3): e59354. DOI:10.1371/journal.pone.0059354.
[7]SAEIDI M, MASOUD A, SHAKIBA Y, et al.Immunomodulatory effects of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells[J]. Iran J Allergy Asthma Immunol, 2013, 12(1): 37-49. DOI:012.01/ijaai.3749.
[8]JIANG F R, JIANG R L, ZHU X J, et al. Genipin inhibits TNF-α-induced vascular smooth muscle cell proliferation and migration via induction of HO-1[J]. PLoS ONE, 2013, 8(8): e74826. DOI:10.1371/journal.pone.0074826.
[9]FREISE C, QUERFELD U. Thelignan (+)-episesamin interferes with TNF-α-induced activation of VSMC via diminished activation of NF-κB, ERK1/2 and AKT and decreased activity of gelatinases[J]. Acta Physiol (Oxf), 2015, 213(3): 642-652. DOI:10.1111/apha.12400.
[10]吴西军, 刘俊峰, 何志旭. 间充质干细胞对肺动脉高压的治疗作用及其对肿瘤坏死因子α/活化T淋巴细胞核因子的影响[J]. 中华实用儿科临床杂志, 2017, 32(13): 1018-1021. DOI:10.3760/j.issn.2095-428X.2017.13.015.
WU X J, LIU J F, HE Z X. Theraeutic effect of mesenchymal stem cell on pulmonary hypertension and its influence on tumer necrosis factorα/nuclear factor of activated T cells[J]. Chin J Appl Clin Pediatr ,2017, 32(13): 1018-1021. DOI: 10.3760/j.issn.2095-428X.2017.13.015.
[11]牛志浩, 刘庆, 刘俊峰, 等. 间充质干细胞条件培养基对炎症介导的肺动脉血管平滑肌细胞增殖调控的研究[J]. 贵州医科大学学报, 2018, 43(6): 641-645. DOI: 10.19367/j.cnki.1000-2707.2018.06.005.
NIU Z H, LIU Q, LIU J F, et al. Regulation of mesenchymal stem cell conditioned medium on proliferation of pulmonary artery smooth muscle cells mediated by inflammation[J]. J Guizhou Med Univ, 2018, 43(6): 641-645. DOI: 10.19367/j.cnki.1000-2707.2018.06.005.
[12]SAID S I, HAMIDI S A, GONZALEZ BOSC L. Asthma and pulmonary arterial hypertension: do they share a key mechanism of pathogenesis?[J].Eur Respir J, 2010, 35(4): 730-734. DOI: 10.1183/09031936.00097109.
[13]SZEMA A M, FORSYTH E, YING B, et al. NFATc3 and VIP in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease[J]. PLoS ONE, 2017, 12(1): e0170606. DOI: 10.1371/journal.pone.0170606.
[14]ROWLANDS D J, ISLAM M N, DAS S R, et al. Activation of TNFR1 ectodomain shedding by mitochondrial Ca2+ determines the severity of inflammation in mouse lung microvessels[J]. J Clin Invest, 2011, 121(5): 1986-1999. DOI: 10.1172/JCI43839.
[15]YANG W S, MOON S Y, LEE M J, et al. Diosgenin, an activator of 1, 25D3-MARRS receptor/ERp57, attenuates the effects of TNF-α by causing ADAM10-dependent ectodomain shedding of TNF receptor 1[J]. Cell Physiol Biochem, 2017, 43(6): 2434-2445. DOI: 10.1159/000484396.
[16]CHEN K, WANG D, DU W T, et al. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism[J]. Clin Immunol, 2010, 135(3): 448-458. DOI: 10.1016/j.clim.2010.01.015.
[17]WEN Y C, DU M K, LI M W, et al. EphA2-positive human umbilical cord-derived mesenchymal stem cells exert anti-fibrosis and immunomodulatory activities via secretion of prostaglandin E2[J]. Taiwan J Obstet Gynecol, 2018, 57(5): 722-725. DOI: 10.1016/j.tjog.2018.08.020.
[18]NEMETH K, KEANE-MYERS A, BROWN J M, et al. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma[J]. Proc Natl Acad Sci U S A, 2010, 107(12): 5652-5657. DOI: 10.1073/pnas.0910720107.
[19]XUAN J, FENG W, AN Z T, et al. Anti-TGFβ-1 receptor inhibitor mediates the efficacy of the human umbilical cord mesenchymal stem cells against liver fibrosis through TGFβ-1/Smad pathway[J]. Mol Cell Biochem, 2017, 429(1/2): 113-122. DOI: 10.1007/s11010-017-2940-1.
[20]LI P, LI S H, WU J, et al. Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege[J]. J Cell Mol Med, 2013, 17(9): 1136-1145. DOI: 10.1111/jcmm.12092.
[21]BABER S R, DENG WW, MASTER R G, et al. Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction[J]. Am J Physiol Heart Circ Physiol, 2007, 292(2): H1120-H1128. DOI: 10.1152/ajpheart.00173.2006.
[22]LUAN Y, ZHANG X, KONG F, et al. Mesenchymal stem cell prevention of vascular remodeling in high flow-induced pulmonary hypertension through a paracrine mechanism[J]. Int Immunopharmacol, 2012, 14(4): 432-437. DOI: 10.1016/j.intimp.2012.08.001.
[23]FRID M G, BRUNETTI J A, BURKE D L, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macrophage lineage[J]. Am J Pathol, 2006, 168(2): 659-669. DOI: 10.2353/ajpath.2006.050599.
[24]YOUNG J M, WILLIAMS D R, THOMPSON AA R. Thin air, thick vessels: historical and current perspectives on hypoxic pulmonary hypertension[J]. Front Med (Lausanne), 2019, 6: 93. DOI: 10.3389/fmed.2019.00093.